Financials

  • Market Capitalization 12.68 B
  • Employee 915
  • Founded 2011
  • CEO Paul A. Friedman
  • Website www.madrigalpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000QS6NV8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-34.99
Fiyat/satışlar oranı
11.04

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
706
JAZZ
Jazz Pharmaceuticals plc - Ordinary Shares
240.30 USD+0.95%-2.59%+4.08%+71.64%15.08 B USD
740
EXEL
Exelixis, Inc. - Common Stock
55.79 USD+0.04%+0.22%+4.59%+42.90%14.02 B USD
820
SMMT
Summit Therapeutics Inc. - Common Stock
15.09 USD-2.46%-3.70%+6.87%-24.02%11.71 B USD
824
AXSM
Axsome Therapeutics, Inc. - Common Stock
235.91 USD+0.28%-5.28%-7.50%+81.19%12.14 B USD

Haberler